Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .

Essential

These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.
Statistics

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds

© dkfz.de

Tumors of the digestive system represent the most frequent malignant diseases affecting men and women to the same extent. They are associated with poor prognosis: Colorectal cancer (CRC) is one of the three most common causes of cancer-related deaths in the Western World. Pancreatic ductal adenocarcinoma (PDAC) is associated with limited treatment options. Hepatocellular carcinoma (HCC) accounts for most liver cancers and is diagnosed in more than half a million people worldwide each year. Despite substantial progress in cancer research, covering tumor initiation, tumor progression, and metastatic dissemination, the molecular and cellular mechanisms driving gastro-intestinal tumors are poorly understood. Therefore, it is of tremendous interest to identify and characterize the key players in these processes using CRC, PDAC and HCC as model entities. In this topic the members of the consortium will make a joint effort to investigate tumor initiation and progression covering not only tumor-centric questions but also considering tumor-microenvironmental aspects.

to top
powered by webEdition CMS